Fibrin Glue Market Analysis 2023

More documents

Recommendations

Info

Fibrin Glue Market Fibrin glues are usually used for wound closure, bronchial fistulas, repairing dura tears and haemostasis for liver and spleen trauma. Many companies are investing in research and development for expanding the indications for which fibrin glue can be used in addition to their existing indications. In October 2016, Ethicon received USFDA approval for an expanded indication for EVARREST Fibrin Sealant Patch. The expanded indication supported the use of EVARREST as an adjunctive hemostat for a broad range of patients and surgical situations. The expanded indication was based on a cardiovascular clinical study that demonstrated EVARREST’s superior hemostatic efficacy. The expanded indication is major trend being observed in the global fibrin glue market, which has led to the increase in the use of the fibrin glues. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=fibringlue-market Copyright © P&S Market Research
Fibrin Glue Market Some of the key players operating in the global fibrin glue market include Vivostat A/S, Kaketsuken, Johnson & Johnson, Baxter International Inc., CSL Behring, Zimmer Biomet Holdings, Inc., Takeda Pharmaceutical Company Limited, Mallinckrodt Plc, Shanghai RAAS Blood Products Co. Ltd. and Hualan Biological Engineering Inc. Browse report sample at: https://www.psmarketresearch.com/market-analysis/fibrin-gluemarket/report-sample Copyright © P&S Market Research
Page 1 and 2: Fibrin Glue Market to Witness a CAG
Page 3: Fibrin Glue Market Geographically,

Fibrin Glue Market Analysis 2023

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?